Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis

Human Molecular Genetics

Volumn 19, Issue 4, 2009, Pages 707-719

  Karp, David R ^a,p   Marthandan, Nishanth ^a   Marsh, Steven G E ^b,p   Ahn, Chul ^c   Arnett, Frank C ^d   DeLuca, David S ^e,p   Diehl, Alexander D ^f   Dunivin, Raymond ^g,p   Eilbeck, Karen ^h   Feolo, Michael ^g,p   Guidry, Paula A ^a   Helmberg, Wolfgang ^i,p   Lewis, Suzanna ^j   Mayes, Maureen D ^d   Mungall, Chris ^j   Natale, Darren A ^k   Peters, Bjoern ^l,p   Petersdorf, Effie ^m,p   Reveille, John D ^d   Smith, Barry ⁿ   Thomson, Glenys ^o   Waller, Matthew J ^b   Scheuermann, Richard H ^a,c,p   more..

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d Boston MA 02115 ^*  (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f JACKSON LABORATORY   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ MEDICAL UNIVERSITY OF GRAZ   (Austria)

^j LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^k GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^l LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^m Fred Hutchinson Cancer Research Center   (United States)

ⁿ UNIVERSITY AT BUFFALO   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p National Institute of Allergy and Infectious Disease   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; HLA ANTIGEN; HLA-DRB1 ANTIGEN;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE ANALYSIS; SYSTEMIC SCLEROSIS; CHEMISTRY; CONFORMATION; GENETICS;

GENETIC VARIATION; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; MOLECULAR CONFORMATION; SCLERODERMA, SYSTEMIC;

EID: 77950363736     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp521     Document Type: Article

References (39)

1. Robinson, J., Malik, A., Parham, P., Bodmer, J.G. and Marsh, S.G. (2000) IMGT/HLA database-a sequence database for the human major histocompatibility complex. Tissue Antigens, 55, 280-287.
2. Frahm, N., Baker, B. and Brander, C. (2008). Identification and Optimal Definition of HIV-derived cytotoxic T-lymphocyte (CTL) epitopes for the study of CTL escape, functional avidity, and viral evolution. In Korber, B.T., Haynes, B.C., Koup, R., Moore, J.P., Walker, B.D. and Watkins, D.I. (eds), HIV Molecular Immunology 2008. Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, NM, pp. 3-24.
3. Lautscham, G., Rickinson, A. and Blake, N. (2003) TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus. Microbes Infect., 5, 291-299.
4. Miles, J.J., Elhassen, D., Borg, N.A., Silins, S.L., Tynan, F.E., Burrows, J.M., Purcell, A.W., Kjer-Nielsen, L., Rossjohn, J., Burrows, S.R. et al. (2005) CTL recognition of a bulged viral peptide involves biased TCR selection. J. Immunol., 175, 3826-3834.
5. Tynan, F.E., Elhassen, D., Purcell, A.W., Burrows, J.M., Borg, N.A., Miles, J.J., Williamson, N.A., Green, K.J., Tellam, J., Kjer-Nielsen, L. et al. (2005) The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J. Exp. Med., 202, 1249-1260.
6. Khan, M.A., Mathieu, A., Sorrentino, R. and Akkoc, N. (2007) The pathogenetic role of HLA-B27 and its subtypes. Autoimmun. Rev., 6, 183-189.
7. Reveille, J.D. (2006) Major histocompatibility genes and ankylosing spondylitis. Best Pract. Res. Clin. Rheumatol., 20, 601-609.
8. Imboden, J.B. (2009) The immunopathogenesis of rheumatoid arthritis. Annu. Rev. Pathol., 4, 417-434.
9. Newton, J.L., Harney, S.M., Wordsworth, B.P. and Brown, M.A. (2004) A review of the MHC genetics of rheumatoid arthritis. Genes Immun., 5, 151-157.
10. Erlich, H., Valdes, A.M., Noble, J., Carlson, J.A., Varney, M., Concannon, P., Mychaleckyj, J.C., Todd, J.A., Bonella, P., Fear, A.L. et al. (2008) HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes, 57, 1084-1092.
11. Thomson, G., Valdes, A.M., Noble, J.A., Kockum, I., Grote, M.N., Najman, J., Erlich, H.A., Cucca, F., Pugliese, A., Steenkiste, A. et al. (2007) Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens, 70, 110-127.
12. Salamon, H., Tarhio, J., Ronningen, K. and Thomson, G. (1996) On distinguishing unique combinations in biological sequences. J. Comput. Biol., 3, 407-423.
13. Valdes, A.M., McWeeney, S. and Thomson, G. (1997) HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: application of the haplotype method. Am. J. Hum. Genet., 60, 717-728.
14. Valdes, A.M. and Thomson, G. (1997) Detecting disease-predisposing variants: the haplotype method. Am. J. Hum. Genet., 60, 703-716.
15. Gladman, D.D., Keystone, E.C., Baron, M., Lee, P., Cane, D. and Mervert, H. (1981) Increased frequency of HLA-DR5 in scleroderma. Arthritis Rheum., 24, 854-856.
16. Arnett, F.C., Bias, W.B., McLean, R.H., Engel, M., Duvic, M., Goldstein, R., Freni-Titulaer, L., McKinley, T.W. and Hochberg, M.C. (1990) Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies. J. Rheumatol., 17, 1029-1035.
17. Reveille, J.D., Durban, E., MacLeod-St Clair, M.J., Goldstein, R., Moreda, R., Altman, R.D. and Arnett, F.C. (1992) Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J. Clin. Invest., 90, 973-980.
18. Briggs, D., Stephens, C., Vaughan, R., Welsh, K. and Black, C. (1993) A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis. Arthritis Rheum., 36, 943-954.
19. Kuwana, M., Kaburaki, J., Okano, Y., Inoko, H. and Tsuji, K. (1993) The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J. Clin. Invest., 92, 1296-1301.
20. Kuwana, M., Kaburaki, J., Mimori, T., Tojo, T. and Homma, M. (1993) Autoantigenic epitopes on DNA topoisomerase I. Clinical and immunogenetic associations in systemic sclerosis. Arthritis Rheum., 36, 1406-1413.
21. Morel, P.A., Chang, H.J., Wilson, J.W., Conte, C., Falkner, D., Tweardy, D.J. and Medsger, T.A. Jr (1995) HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies. Hum. Immunol., 42, 35-42.
22. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T. et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25, 25-29.
23. Agarwal, S.K., Tan, F.K. and Arnett, F.C. (2008) Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum. Dis. Clin. North. Am., 34, 17-40.
24. Arnett, F.C. (1995) HLA and autoimmunity in scleroderma (systemic sclerosis). Int. Rev. Immunol., 12, 107-128.
25. Reveille, J.D., Owerbach, D., Goldstein, R., Moreda, R., Isern, R.A. and Arnett, F.C. (1992) Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J. Clin. Invest., 89, 1208-1213.
26. Morel, P.A., Chang, H.J., Wilson, J.W., Conte, C., Saidman, S.L., Bray, J.D., Tweardy, D.J. and Medsger, T.A. Jr (1994) Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele. Hum. Immunol., 40, 101-110.
27. Whyte, J., Artlett, C., Harvey, G., Stephens, C.O., Welsh, K., Black, C., Maddison, P.J. and McHugh, N.J. (1994) HLA-DQB1 associations with anti-topoisomerase-1 antibodies in patients with systemic sclerosis and their first degree relatives. United Kingdom Systemic Sclerosis Study Group. J. Autoimmun., 7, 509-520.
28. Arnett, F.C., Reveille, J.D., Goldstein, R., Pollard, K.M., Leaird, K., Smith, E.A., Leroy, E.C. and Fritzler, M.J. (1996) Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum., 39, 1151-1160.
29. Arnett, F.C., Gourh, P., Shete, S., Ahn, C.W., Honey, R., Agarwal, S.K., Tan, F.K., McNearney, T., Fischbach, M., Fritzler, M.J. et al. (2009) Major histocompatibility complex (MHC) class II alleles, haplotypes, and epitopes which confer susceptibility or protection in the fibrosing autoimmune disease systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann. Rheum. Dis., ard.2009.111906.
30. Dunckley, H., Jazwinska, E.C., Gatenby, P.A. and Serjeantson, S.W. (1989) DNA-DR typing shows HLA-DRw11 RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma. Tissue Antigens, 33, 418-420.
31. Lancaster, A. (2006) Interplay of selection and molecular function in HLA genes. PhD thesis, Integrative Biology, University of California at Berkley, Berkley, CA.
32. Smith, K.J., Pyrdol, J., Gauthier, L., Wiley, D.C. and Wucherpfennig, K.W. (1998) Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J. Exp. Med., 188, 1511-1520.
33. Kaas, Q., Ruiz, M. and Lefranc, M.P. (2004) IMGT/3Dstructure-DB and IMGT/StructuralQuery, a database and a tool for immunoglobulin, T cell receptor and MHC structural data. Nucleic Acids Res., 32, D208-D210.
34. Diehl, A.D., Lee, J.A., Scheuermann, R.H. and Blake, J.A. (2007) Ontology development for biological systems: immunology. Bioinformatics, 23, 913-915.
35. Marsh, S.G., Albert, E.D., Bodmer, W.F., Bontrop, R.E., Dupont, B., Erlich, H.A., Geraghty, D.E., Hansen, J.A., Hurley, C.K., Mach, B. et al. (2005) Nomenclature for factors of the HLA system, 2004. Tissue Antigens, 65, 301-369.
36. Thomson, G., Barcellos, L.F. and Valdes, A.M. (2008) Searching for additional disease loci in a genomic region. Adv. Genet., 60, 253-292.
37. Hennecke, J., Carfi, A. and Wiley, D.C. (2000) Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J., 19, 5611-5624.
38. Moreland, J.L., Gramada, A., Buzko, O.V., Zhang, Q. and Bourne, P.E. (2005) The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications. BMC Bioinformatics, 6,21.
39. Guex, N. and Peitsch, M.C. (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis, 18, 2714-2723.